InsidersTradesSigma
Follow the 엑셀세라퓨틱스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엑셀세라퓨틱스 has logged 4 insider filings. Market capitalisation: €18.7bn. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: 오수림. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Excel Therapeutics 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于创新疗法的开发。